13th International Conference on Practical Applications of Computational Biology & Bioinformatics (PACBB)

      Date
      Jun 26, 2019 - Jun 28, 2019
      Location
      Ávila, Spain
      The 13th International Conference on Practical Applications of Computational Biology & Bioinformatics (PACBB) aims to promote the interaction among the scientific community to discuss applications of CS/AI with an interdisciplinary character, exploring the interactions between sub-areas of CS/AI, Bioinformatics, Chemoinformatics, and Systems Biology. Brand new ideas in these fields are sought, as well as substantial and relevant revisions and actualizations of previously presented work, project summaries, and PhD thesis presented or not. The success of Bioinformatics in recent years has been prompted by research in Molecular Biology and Molecular Medicine in several initiatives. These initiatives gave rise to an exponential increase in the volume and diversification of data, including nucleotide and protein sequences and annotations, high-throughput experimental data, biomedical literature, among many others. Systems Biology is a related research area that has been replacing the reductionist view that dominated Biology research in the last decades, requiring the coordinated efforts of biological researchers with those related to data analysis, mathematical modeling, computer simulation and optimization.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.